Printer Friendly

ThyssenKrupp agrees electrolysis plant JV with Italya[euro](tm)s De Nora.

M2 EQUITYBITES-November 5, 2013-ThyssenKrupp agrees electrolysis plant JV with Italya[euro](tm)s De Nora(C)2013 M2 COMMUNICATIONS http://www.m2.com

5 November 2013 - German steel giant ThyssenKrupp AG (ETR:TKA) said today its plant engineering and construction arm ThyssenKrupp Industrial Solutions had agreed to set up a joint venture in the electrolysis area with Italian electrochemical technologies supplier Industrie De Nora SpA.

ThyssenKrupp did not give financial details on the deal, which is pending clearances by the supervisory bodies and competition regulators.

ThyssenKrupp Industrial Solutions will hold a majority stake in the new firm, which will be dubbed ThyssenKrupp Uhde Chlorine Engineers.

The venture, which is seen to generate annual sales in the mid three-digit million euro range, will combine the firms' engineering, procurement and construction activities for electrolysis plants, expanding their technological platforms and enlarging their global reach, ThyssenKrupp said. It will be based in Dortmund, Germany and will have offices also in Okayama, Tokyo, Shanghai, Milan and Houston.

The parties have already been collaborating via a joint venture on licensing electrolysis processes.

Commenting on the move, the German group's CEO Heinrich Hiesinger stressed that plant engineering and construction is a key growth area for ThyssenKrupp.

According to ThyssenKrupp Industrial Solutions's CEO Hans Christoph Atzpodien, the two companies have complementary technologies and geographical market coverage.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2013 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Nov 5, 2013
Words:230
Previous Article:NEA, Air Liquide unit participate in USD11.5m Terrajoule funding round.
Next Article:T1D Exchange receives USD2.8m research grant from Juvenile Diabetes Research Foundation.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters